Table 1.

Required and optimal parameters for a surrogate endpoint in rectal cancer clinical trials

Required elements	Optimal additional elements
Correlates with the true endpoint (individual level association)	Surrogate endpoint achieved at or near completion of the experimental intervention
Effect of treatment correlates between surrogate and true endpoint (trial level association)	High reproducibility across different study designs and interventions
	Low/no added cost
	Low/no added complexity